Chemical suppression of an oncogenic splicing variant of AIMP2 induces tumour regression

Worldwide Overview of the Current Status of Lung Cancer Diagnosis and Treatment

(2012) Paul A. Bunn   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Structure of a hepatitis C virus RNA domain in complex with a translation inhibitor reveals a binding mode reminiscent of riboswitches

(2012) S. M. Dibrov et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Splicing variant of AIMP2 as an effective target against chemoresistant ovarian cancer

(2012) Jin Woo Choi et al.   Journal of Molecular Cell Biology

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Osteopontin-c Splicing Isoform Contributes to Ovarian Cancer Progression

(2011) T. M. Tilli et al.   MOLECULAR CANCER RESEARCH

Cancer-Associated Splicing Variant of Tumor Suppressor AIMP2/p38: Pathological Implication in Tumorigenesis

(2011) Jin Woo Choi et al.   PLoS Genetics

Multidirectional tumor-suppressive activity of AIMP2/p38 and the enhanced susceptibility of AIMP2 heterozygous mice to carcinogenesis

(2009) J. W. Choi et al.   CARCINOGENESIS

RNA and Disease

(2009) Thomas A. Cooper et al.   CELL

AIMP2 promotes TNF -dependent apoptosis via ubiquitin-mediated degradation of TRAF2

(2009) J. W. Choi et al.   JOURNAL OF CELL SCIENCE

AIMP2/p38, the scaffold for the multi-tRNA synthetase complex, responds to genotoxic stresses via p53

(2008) J. M. Han et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA